Searchable abstracts of presentations at key conferences in endocrinology

ea0092ps3-24-03 | Thyroid Eye Disease | ETA2023

Teprotumumab efficacy in european and us study sites participating in the phase 2, optic (Phase 3) and optic-x pivotal trials

Kahaly George , Fu Qianhong , Holt Robert

Background: Teprotumumab showed significant improvements vs placebo for the treatment of thyroid eye disease (TED) in clinical trials1,2 and is approved in the United States (US) but currently not in the EU. Differences exist in baseline patient demographics and characteristics between EU and US patients. Here we examine outcomes in these 2 cohorts.Methods: Data from the EU and US sites for patients in the teprotumumab group (n =121) from the in...

ea0090ep903 | Reproductive and Developmental Endocrinology | ECE2023

Obesity, insulin resistance and hyperandrogenism are implicated in the progression of liver stiffness (LS) in women with PCOS

Stefanaki Aikaterini , Karagiannakis Dimitrios , Georgiopoulos Georgios , Michala Lina , Ilias Ioannis , Vlachogiannakos Jiannis , Papatheodoridis George , Mastorakos George

Introduction: Non-alcoholic fatty liver disease (NAFLD) has become the leading cause of chronic liver disorders in Western countries, encompassing a spectrum of diseases ranging from simple steatosis to liver fibrosis and cirrhosis. Polycystic Ovary Syndrome (PCOS), the most common endocrine disorder of women during the reproductive period, is often implicated with NAFLD.Aim: To investigate the potential involvement of PCOS on the aggravation of NAFLD by...

ea0063p416 | Adrenal and Neuroendocrine Tumours 2 | ECE2019

High prevalence of autonomous aldosterone secretion in patients with type 2 Diabetes Mellitus and arterial hypertension. The effect of SGLT2 inhibitors on renin-angiotensin-aldosterone system

Tyfoxylou Ernestini , Papanastasiou Labrini , Piaditis George , Voulgaris Nikolaos , Chrousos George , Kounadi Theodora

Introduction: The causes of arterial hypertension in diabetic and non-diabetic hypertensive patients are still not clear. However, in recent studies in non-diabetic hypertensive patients (NDHP) we observed dysregulation of aldosterone (ALD) secretion either in the form of autonomous secretion or as hyperesponse to stress. To the best of our knowledge, a similar study in hypertensive patients with type 2 Diabetes Mellitus (DHP) has not been conducted yet....

ea0041ep808 | Obesity | ECE2016

Increased Urocortin 3 blood levels in morbidly obese subjects are reduced after excess body weight reduction with laparoscopic sleeve gastrectomy

Bargiota Alexandra , Papamargaritis Dimitris , Sioka Eleni , Zacharoulis Dimitris , Tzovaras George , Koukoulis George

Aim: To measure Urocortin3 (Ucn3) blood levels in morbidly obese (MO) non diabetic patients before and after laparoscopic sleeve gastrectomy (LSG) for excess body weight reduction and explore its relationship with b-cell function. Ucn3 is involved in insulin secretion in the presence of nutrient excess, a key feature of obesity, and may be an integral part of the compensation of β-cells function.Methods: Nine MO patients who underwent LSG and 11 hea...

ea0032oc5.2 | Reproduction | ECE2013

The (TAAAA)n polymorphism in the SHBG gene is related to prenatal androgenization of female fetus: possible implications of the developmental origin of metabolic disorders

Pamporaki Christina , Xita Nectaria , Lazaros Leandros , Makridimas George , Georgiou Ioannis , kolios George , Plachouras Nikolaos , Tsatsoulis Agathocles

Introduction: The aim of this study was to examine whether the distribution of SHBG (TAAAA)n repeat variants contributes to the exposure of the female fetus to androgen excess, by influencing the, in utero, androgen availability.Methods: The study population consisted of 100 pregnant women that carried female fetuses and underwent the procedure of amniocentesis due to age (older than 35). Blood samples and amniotic fluid samples were dr...

ea0022p150 | Cardiovascular endocrinology and lipid metabolism | ECE2010

Genetic polymorphisms associated with cardiovascular risk correlate with dyslipidaemia in healthy postmenopausal women

Papadimitriou Dimitra , Kaparos George , Rizos Dimitrios , Armeni Eleni , Creatsa Maria , Alexandrou Andreas , Christodoulakos George , Lambrinoudaki Irene

Objective: To assess the impact of genetic polymorphisms associated with increased cardiovascular risk on the lipid profile in healthy postmenopausal women.Methods: The study population consisted of 84 women between 49–69 years who had been menopausal for at least one year. The genetic polymorphisms examined were the following: Glycoprotein IIIa leu33pro, Apolipoprotein E2/E3/E4, Methylenotetrahydrofolate reductase ala222val, Apolipoprotein B arg350...

ea0022p738 | Steroid metabolism & action | ECE2010

Androgenicity is enhanced in the presence of ala222val polymorphism in healthy postmenopausal women

Papadimitriou Dimitra , Kaparos George , Rizos Dimitrios , Armeni Eleni , Kreatsa Maria , Alexandrou Andreas , Christodoulakos George , Lambrinoudaki Irene

Objective: To assess the interrelation of the MTHFR ala222val polymorphism, correlated with increased rates of cardiovascular disease, with indices of androgenicity in healthy postmenopausal women.Methods: The population of this cross-sectional study consisted of 84 healthy women who had been menopausal for at least one year. The examined polymorphism was Methylenetetrahydrofolate reductase ala222val, while the hormonal assays included Testosterone, Sex ...

ea0020p448 | Obesity and Metabolism | ECE2009

Evidence of increased cardiovascular risk in patients with non-secreting unilateral adrenocortical adenomas

Androulakis Ioannis , Kollias George , Markou Athina , Papanastasiou Lambrini , Angnostou Tilemachos , Papamichael Christos , Piaditis George , Kaltsas Gregory

Background: Incidentally discovered adrenal adenomas (AA) are associated with increased prevalence of hypertension, obesity, and impaired glucose tolerance, all established risk factors for cardiovascular (CV) morbidity. However, most studies were performed in patients with AA and autonomous cortsisol and/or aldosterone secretion, whereas the presence of cardiovascular risk in patients with non-secreting AA has not been looked into detail.Methods: Cardio...

ea0056oc14.2 | What is new in gestational and type 1 diabetes? | ECE2018

Profiling of activation patterns of placental mTOR in pregnancies complicated by gestational diabetes mellitus

Papadopoulou Anna , Valsamakis George , Thymara Irini , Laryngaki Anastasia , Theodorou Spyridoula , Grammatopoulos Dimitris , Papaevangelou Vasiliki , Mastorakos George

The mammalian target of rapamycin (mTOR) is a serine kinase that couples energy and nutrient abundance to cell growth and is critically involved in the onset and progression of diabetes, cancer and ageing. Placental mTOR is involved in nutrient sensing and transfer to the fetus. Animal models suggest that placental mTOR is upregulated in pregnancies complicated by gestational diabetes (GDM). Our aim was to characterize expression, and cellular localization of mTOR and whether ...

ea0073aep188 | Diabetes, Obesity, Metabolism and Nutrition | ECE2021

Feasibility study of IoT telemonitoring for elderly patients with type 2 diabetes mellitus: Results of the Greek pilot of the ACTIVAGE multicenter randomised control trial

Dafoulas George , Karaberi Christina , Segkouli Sofia , Dimakopoulos George , Votis Konstantinos , Tzovaras Dimitrios , Bargiota Alexandra

IntroductionThe aim of the present feasibility study was to examine the impact of an Internet of Things (IoT) telemonitoring program, for elderly patients with type 2 diabetes mellitus (DMT2) on glycemic control.MethodsIn this feasibility, prospective, randomized, single-blinded, multicenter study elderly patients with DMT2 capable to use the IoT telemonitoring device, with an HbA1c > 7.5 were followed-up...